Efficacy and safety of etanercept biosimilar rhTNFR-Fc in Chinese patients with juvenile idiopathic arthritis: An open-label multicenter observational study

• मुख्य लेखकों: Xuefeng Xu (लेखक), Xiaohui Liu (लेखक), Wenjie Zheng (लेखक), Jihong Xiao (लेखक), Xiaozhong Li (लेखक), Ling Wu (लेखक), Lixia Zou (लेखक), Qian Ouyang (लेखक), Yaoyao Shangguan (लेखक), Kezhao Lin (लेखक), Xiaomei Dai (लेखक), Yuanling Chen (लेखक), Yiping Xu (लेखक), Jianqiang Wu (लेखक), Meiping Lu (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

BackgroundEtanercept biosimilar recombinant human TNF-α receptor II: IgG Fc fusion protein (rhTNFR-Fc) has showed its efficacy and safety in Chinese patients with rheumatoid arthritis. However, data on rhTNFR-Fc's application in juvenile idiopathic arthritis (JIA) is limited.MethodsA prospectiv...